Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-04-21
DOI
10.3389/fphar.2023.1179208
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Suicide attempts in adolescents with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor therapy
- (2023) Meliksah Arslan et al. Journal of Cystic Fibrosis
- Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles
- (2022) Simon Y. Graeber et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Dose adjustments of Elexacaftor/Tezacaftor/Ivacaftor in response to mental health side effects in adults with cystic fibrosis
- (2022) Spoletini G et al. Journal of Cystic Fibrosis
- Evaluating the Effect of Kaftrio on Perspectives of Health and Wellbeing in Individuals with Cystic Fibrosis
- (2022) Sean A. Aspinall et al. International Journal of Environmental Research and Public Health
- Sex and Gender in lung diseases and sleep disorders: A state of the art review. Part 2
- (2022) Amik Sodhi et al. CHEST
- Non-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor
- (2022) Isabelle Fajac et al. Journal of Cystic Fibrosis
- Cystic Fibrosis
- (2022) Kristina Montemayor et al. MEDICAL CLINICS OF NORTH AMERICA
- A survey assessing the impact of COVID‐19 and elexacaftor/tezacaftor/ifavacaftor on both physical and mental health in adults with cystic fibrosis
- (2022) Colleen Sakon et al. PEDIATRIC PULMONOLOGY
- Rapid Improvement After Starting Elexacaftor-tezacaftor-ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease
- (2021) Pierre-Régis Burgel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations
- (2021) Kristina Montemayor et al. Journal of Cystic Fibrosis
- Triple Therapy for Cystic Fibrosis Phe508del–Gating and –Residual Function Genotypes
- (2021) Peter J. Barry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles
- (2021) Simon Y. Graeber et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical Effectiveness of Elexacaftor/Tezacftor/Ivacaftor in People with Cystic Fibrosis
- (2021) David P Nichols et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mental status changes during elexacaftor/tezacaftor / ivacaftor therapy
- (2021) Suyeon Heo et al. Journal of Cystic Fibrosis
- Assessing Psychosocial Distress in Cystic Fibrosis: Validation of the ‘Distress in Cystic Fibrosis Scale’
- (2021) Caroline Finlay et al. JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS
- Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis
- (2020) Emily DiMango et al. Journal of Cystic Fibrosis
- Decreased survival in cystic fibrosis patients with a positive screen for depression
- (2020) Michael S. Schechter et al. Journal of Cystic Fibrosis
- Trikafta and Psychopathology in Cystic Fibrosis: A Case Report
- (2020) William Tindell et al. PSYCHOSOMATICS
- Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis
- (2020) Nader Salari et al. Globalization and Health
- Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for ≥24 Weeks in People With CF and ≥1 F508del Allele: Interim Results of an Open-Label Phase Three Clinical Trial
- (2020) Matthias Griese et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Rates of depression and anxiety in Italian patients with cystic fibrosis and parent caregivers: Implementation of the Mental Health Guidelines
- (2020) Sonia Graziano et al. RESPIRATORY MEDICINE
- The future of cystic fibrosis care: a global perspective
- (2019) Scott C Bell et al. Lancet Respiratory Medicine
- Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
- (2019) Harry G M Heijerman et al. LANCET
- Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
- (2019) Peter G. Middleton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications
- (2019) Marcus A Mall et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Symptoms of depression impact the course of lung function in adolescents and adults with cystic fibrosis
- (2015) Astrid Fidika et al. BMC Pulmonary Medicine
- Prevalence of Depression and Antidepressant Therapy Use in a Pediatric Cystic Fibrosis Population
- (2014) Cady Ploessl et al. ANNALS OF PHARMACOTHERAPY
- Gender Differences in Outcomes of Patients with Cystic Fibrosis
- (2014) Cayce L. Harness-Brumley et al. JOURNAL OF WOMENS HEALTH
- Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries
- (2014) Alexandra L Quittner et al. THORAX
- Reliability and validity of the beck depression inventory-fast screen for medical patients in the general German population
- (2013) Sören Kliem et al. JOURNAL OF AFFECTIVE DISORDERS
- Relationship Between Anxiety, Depression, and Quality of Life in Adult Patients With Cystic Fibrosis
- (2012) A. M. Yohannes et al. Respiratory Care
- Anxiety and depression in adolescents with CF and their caregivers
- (2011) Tanja Besier et al. Journal of Cystic Fibrosis
- Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample
- (2011) Alexandra L. Quittner et al. QUALITY OF LIFE RESEARCH
- Prevalence of Symptoms of Anxiety and Depression in German Patients With Cystic Fibrosis
- (2010) Lutz Goldbeck et al. CHEST
- Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance
- (2010) Beth A. Smith et al. PEDIATRIC PULMONOLOGY
- The utility of the Beck Depression Inventory Fast Screen (BDI-FS) in a pain clinic population
- (2008) Helen Poole et al. EUROPEAN JOURNAL OF PAIN
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started